Unique Ingredient Identifier 2S7830E561 is listed as a unspecified ingredient
| RN | 9003-39-8 |
| NCIT | C80893 |
| RXCUI | 1310706 |
| INN ID | 4559 |
UNII 2S7830E561 CROSPOVIDONE, UNSPECIFIED is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| IMPLANTATION | PELLET | 2 MG |
| INTRA-ARTICULAR | INJECTION | 0.02 % |
| INTRAMUSCULAR | INJECTION | 0.02 % |
| INTRAUTERINE | SOLUTION | NA |
| ORAL | CAPSULE | 85 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN | 15.91 MG |
| ORAL | CAPSULE, COATED, SOFT GELATIN | 14 MG |
| ORAL | CAPSULE, DELAYED ACTION | 5 MG |
| ORAL | CAPSULE, DELAYED ACTION, ENTERIC COATED | NA |
| ORAL | CAPSULE, DELAYED RELEASE | 13.5 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 40.5 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 1 MG |
| ORAL | CAPSULE, HARD GELATIN | 70 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 10.71 MG |
| ORAL | DISPERSIBLE TABLET | 340 MG |
| ORAL | GRANULE, FOR ORAL SUSPENSION | 75 MG |
| ORAL | PELLET | 75 MG |
| ORAL | POWDER, FOR SUSPENSION | 50 MG/1SCP |
| ORAL | SUSPENSION | 2.5 MG/5ML |
| ORAL | SUSPENSION, SUSTAINED ACTION | 186.8 MG/1PKT |
| ORAL | TABLET | 365 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), COATED | 14 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 110 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL | 9.6 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 100 MG |
| ORAL | TABLET, CHEWABLE | 60 MG |
| ORAL | TABLET, COATED | 104 MG |
| ORAL | TABLET, CONTROLLED RELEASE | NA |
| ORAL | TABLET, DELAYED ACTION | 84 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 50 MG |
| ORAL | TABLET, DELAYED RELEASE | 45 MG |
| ORAL | TABLET, DISPERSIBLE | 10 MG |
| ORAL | TABLET, ENTERIC COATED PARTICLES | 130 MG |
| ORAL | TABLET, EXTENDED RELEASE | 48.2 MG |
| ORAL | TABLET, FILM COATED | 196.7 MG |
| ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 12 MG |
| ORAL | TABLET, FOR SUSPENSION | 125 MG |
| ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 5 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 280 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 15 MG |
| ORAL | TABLET, REPEAT ACTION | 10 MG |
| ORAL | TABLET, SUSTAINED ACTION | 144 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | 15.4 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 5 MG |
| SUBLINGUAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL | 16 MG |
| TOPICAL | EMULSION | 1 %W/W |
| TOPICAL | LOTION | NA |
| TRANSDERMAL | FILM | 3.63 MG |
| TRANSDERMAL | FILM, CONTROLLED RELEASE | 60 MG |
| TRANSDERMAL | FILM, EXTENDED RELEASE | 47.5 MG |
| TRANSDERMAL | PATCH, ELECTRICALLY CONTROLLED | 62 MG |
| VAGINAL | SUPPOSITORY | 116.1 MG |
| VAGINAL | TABLET | 50 MG |